Natdac
Generic Natdac (Tenofovir disoproxil / daclatasvir / sofosbuvir)
Natdac is an oral antiviral medication used to treat chronic hepatitis C infection by inhibiting viral replication and reducing viral load.
Selecteer Doses: 60mg
60mg
28pillen
Natdac $329.99
$274.99
$9.82 per pil
+ Gratis standaard luchtpostservice
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
TOEVOEGEN AAN WINKELWAGENTJE
bespaar: $0.00
60mg
56pillen
Natdac $495.59
$412.99
$7.37 per pil
+ Free trackable courier service
+ pakketbezorgingsverzekering
+ Bij volgende bestellingen ontvang je een korting van 10%.
TOEVOEGEN AAN WINKELWAGENTJE
bespaar: $137.20
Je bestelling wordt veilig verpakt en binnen 24 uur verzonden. Dit is precies hoe je pakket eruit zal zien (foto's van een echt verzendstuk). Het heeft de afmetingen en het uiterlijk van een gewone particuliere brief (9,4x4,3x0,3 inch of 24x11x0,7 cm) en geeft de inhoud niet prijs
Land Verzendmethode Levertijd Prijs  
Levering 14-21 dagen 10$ Tracking# beschikbaar in 4 dagen
Gratis standaard luchtpost voor alle bestellingen met een bedrag vanaf $200
Levering 5-9 dagen 30$ Tracking# beschikbaar in 2 dagen
Gratis traceerbare koeriersdienst voor alle bestellingen vanaf $300
Wereldwijde verzending Vertrouwelijkheid en anonimiteit gegarandeerd
Veilig en zeker Discreet looking packages
Bestellingen worden binnen 24 uur verzonden 100% succesvolle levering
Getuigenissen Productbeschrijving
Er is op dit moment geen beoordeling voor dit product, maar je kunt de eerste zijn om iets toe te voegen of je kunt meer lezen in Testimonials over gerelateerde producten.
Beoordeling Toevoegen

Common use

Natdac combines sofosbuvir, daclatasvir, and tenofovir disoproxil to treat chronic hepatitis C virus (HCV) infection, particularly genotypes 1–6. It works by targeting different stages of the viral life cycle, inhibiting viral RNA polymerase and other viral enzymes, which helps to clear the infection and prevent liver damage.

Dosage and direction

Natdac is taken orally, usually once daily, with or without food, as directed by your healthcare provider. Swallow tablets whole; do not crush or chew. The duration of treatment depends on the type of hepatitis C infection, previous treatment history, and presence of liver complications. Regular monitoring of liver function and viral load is recommended.

Precautions

Inform your doctor if you have kidney or liver disease, HIV infection, or other chronic illnesses. Monitor for signs of fatigue, jaundice, or unusual bleeding. Avoid alcohol or other hepatotoxic substances during treatment.

Contraindications

Do not use Natdac if allergic to sofosbuvir, daclatasvir, tenofovir disoproxil, or any component of the tablet. It is contraindicated in severe liver impairment or if used with certain medications that interact with the drug components.

Possible side effect

Common side effects include headache, fatigue, nausea, diarrhea, and insomnia. Rare but serious side effects may include liver toxicity, severe allergic reactions, or heart rhythm disturbances. Seek medical attention if severe symptoms occur.

Drug interaction

Natdac may interact with amiodarone, rifampin, certain anticonvulsants, and other medications affecting liver enzymes. Inform your doctor of all prescription drugs, over-the-counter products, and supplements you are taking.

Missed dose

If a dose is missed, take it as soon as you remember. Do not take extra doses to make up for a missed dose. Continue the regular schedule.

Overdose

Overdose may cause nausea, vomiting, fatigue, or liver enzyme abnormalities. Seek immediate medical attention if overdose is suspected.

Storage

Store Natdac at room temperature, away from heat, moisture, and direct sunlight. Keep tablets in the original container and out of reach of children.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.